Permanent Supportive Housing Overdose Prevention+ Study

N/ANot Yet RecruitingNCT07214519

NYU Langone Health2,940 enrolled

Overview

This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based practices to prevent tenant overdose and improve tenant health.

Homelessness and housing instability are strongly linked with overdose risk. Permanent supportive housing (PSH) -subsidized housing paired with supportive services-is a key strategy to end homelessness yet supportive housing tenants face high overdose risk due to a confluence of factors. This multi-sector, community-partnered, stepped wedge randomized controlled trial evaluates the impact of a technical assistance intervention designed to support supportive housing agencies in sustainably implementing evidence-based practices to reduce tenant overdose and improve tenant health more broadly. The technical assistance intervention will be delivered to supportive housing agencies in New Jersey and New York who are enrolled in the trial. Outcomes include PSH agency implementation of overdose prevention practices and downstream tenant overdose, substance use, and other health-related outcomes. Outcomes will be assessed using surveys, administrative data, and agency records. This trial is a part of the HEAL Initiative (https://heal.nih.gov/).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

2,940

Conditions

Overdose Substance Use

Interventions

TA InterventionBEHAVIORAL

Technical assistance (TA) intervention designed to support PSH agencies in sustainably implementing evidence-based practices to reduce tenant overdose and improve tenant health more broadly.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

We will be enrolling supportive housing agencies from NY and NJ to participate in this study. Trial enrollment and intervention delivery will occur at the level of the agency. There are anticipated to be 24 supportive housing agencies total that will be enrolled in the study; approximately 6 agencies will be randomly assigned to each of the four intervention waves in the stepped wedge randomized controlled trial. Inclusion Criteria: Supportive Housing Agencies/Individuals who Work at Supportive Housing Agencies: * Serve at least 40 tenants in New York and/or New Jersey * Have a significant concern for overdose (as demonstrated by past year tenant overdose) * Be willing to complete all activities required for participation in the trial Tenants who Live in Supportive Housing Agencies: * Must live in an enrolled Supportive Housing Agency * Must be 18 years and older Exclusion Criteria: * See inclusion criteria.

Locations (1)

NYU Langone Health

New York, New York, United States

Outcomes

Primary Outcomes

Composite Score of Agency-Level Fidelity to Overdose Prevention Evidence-Based Practices

Fidelity will be measured as the extent to which an intervention is implemented as intended by researchers; the specific method of measurement will be determined during the trial's preparatory phase, in consultation with multiple stakeholders. The measurement will comprise a composite score of multiple measures.

Time frame: Baseline, Month 12 (End of Wave 1), Month 19 (End of Wave 2), Month 26 (End of Wave 3), Month 33 (End of Wave 4)

Central Contacts

Kelly Doran, MD

CONTACT

212-263-5850 Kelly.Doran@nyulangone.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.